Congenital fibrinogen disorders: an update P De Moerloose, A Casini, M Neerman-Arbez Seminars in thrombosis and hemostasis 39 (06), 585-595, 2013 | 314 | 2013 |
Risks of venous thromboembolism after cesarean sections: a meta-analysis M Blondon, A Casini, KK Hoppe, F Boehlen, M Righini, NL Smith Chest 150 (3), 572-596, 2016 | 186 | 2016 |
Natural history of patients with congenital dysfibrinogenemia A Casini, M Blondon, A Lebreton, J Koegel, V Tintillier, E De Maistre, ... Blood, The Journal of the American Society of Hematology 125 (3), 553-561, 2015 | 183 | 2015 |
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 182 | 2023 |
Fibrin (ogen) in human disease: both friend and foe R Vilar, RJ Fish, A Casini, M Neerman-Arbez Haematologica 105 (2), 284, 2020 | 175 | 2020 |
Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management A Casini, M Neerman-Arbez, RA Ariëns, P De Moerloose Journal of Thrombosis and Haemostasis 13 (6), 909-919, 2015 | 127 | 2015 |
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19-a Swiss consensus statement by the Working Party Hemostasis A Casini, L Alberio, A Angelillo-Scherrer, P Fontana, B Gerber, L Graf, ... Swiss medical weekly 150, w20247, 2020 | 126 | 2020 |
Clinical features and management of congenital fibrinogen deficiencies A Casini, P de Moerloose, M Neerman-Arbez Seminars in thrombosis and hemostasis, 366-374, 2016 | 125 | 2016 |
A fibrin biofilm covers blood clots and protects from microbial invasion FL Macrae, C Duval, P Papareddy, SR Baker, N Yuldasheva, KJ Kearney, ... The Journal of clinical investigation 128 (8), 3356-3368, 2018 | 115 | 2018 |
Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk‐guided management A Casini, P Fontana, TP Lecompte Journal of Thrombosis and Haemostasis 11 (7), 1215-1227, 2013 | 108 | 2013 |
Laboratory and genetic investigation of mutations accounting for congenital fibrinogen disorders M Neerman-Arbez, P de Moerloose, A Casini Seminars in thrombosis and hemostasis, 356-365, 2016 | 102 | 2016 |
Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH A Casini, A Undas, R Palla, J Thachil, P De Moerloose Journal of Thrombosis and Haemostasis 16 (9), 1887-1890, 2018 | 92 | 2018 |
Subcommittee on Factor XIII and Fibrinogen. Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH A Casini, A Undas, R Palla, J Thachil, P De Moerloose J Thromb Haemost 16 (9), 1887-1890, 2018 | 72 | 2018 |
Clinical consequences and molecular bases of low fibrinogen levels M Neerman-Arbez, A Casini International journal of molecular sciences 19 (1), 192, 2018 | 70 | 2018 |
Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation A Casini, T Brungs, C Lavenu‐Bombled, R Vilar, M Neerman‐Arbez, ... Journal of Thrombosis and Haemostasis 15 (5), 876-888, 2017 | 67 | 2017 |
Acquired factor XIII deficiency: a therapeutic challenge F Boehlen, A Casini, C Chizzolini, B Mansouri, HP Kohler, V Schroeder, ... Thrombosis and haemostasis 109 (03), 479-487, 2013 | 64 | 2013 |
Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders: an EHA consensus report F Rodeghiero, I Pabinger, M Ragni, R Abdul-Kadir, E Berntorp, ... HemaSphere 3 (5), e286, 2019 | 63 | 2019 |
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines P Fontana, A Casini, H Robert-Ebadi, F Glauser, M Righini, M Blondon Swiss medical weekly 150 (2526), w20301-w20301, 2020 | 62 | 2020 |
Pathogenesis and management of thrombotic disease in myeloproliferative neoplasms DRJ Arachchillage, M Laffan Seminars in Thrombosis and Hemostasis 45 (06), 604-611, 2019 | 59 | 2019 |
Management of congenital quantitative fibrinogen disorders: a Delphi consensus A Casini, P de Moerloose, Congenital Fibrinogen Disorders Group, ... Haemophilia 22 (6), 898-905, 2016 | 50 | 2016 |